Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol before elective cesarean section to reduce neonatal respiratory morbidity
PACTR202512711709610Phase 3Completed
- Sponsor
- Ahmed Soliman
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of misoprostol in airway morbidity (2 arms), sponsored by Ahmed Soliman. Primary endpoint: Incidence of neonatal respiratory distress. Started Jun 2024; status: completed.
02
Drugs
misoprostol
03
Conditions
airway morbidity
Beyond the preview
Go deeper on PACTR202512711709610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202512711709610.